Multicenter clinical trials are recruiting study participants to understand the clinical and immunological benefits of IL-7 treatment in COVID-19 patients (NCT04379076, NCT04407689, NCT04426201, NCT04442178, NCT04927169). This evidence concerns the gene IL7 and COVID-19.